We have investigated the potential role of contactin and contactin-associated protein (Caspr) in the axonal–glial interactions of myelination. In the nervous system, contactin is expressed by neurons, oligodendrocytes, and their progenitors, but not by Schwann cells. Expression of Caspr, a homologue of Neurexin IV, is restricted to neurons. Both contactin and Caspr are uniformly expressed at high levels on the surface of unensheathed neurites and are downregulated during myelination in vitro and in vivo. Contactin is downregulated along the entire myelinated nerve fiber. In contrast, Caspr expression initially remains elevated along segments of neurites associated with nascent myelin sheaths. With further maturation, Caspr is downregulated in the internode and becomes strikingly concentrated in the paranodal regions of the axon, suggesting that it redistributes from the internode to these sites. Caspr expression is similarly restricted to the paranodes of mature myelinated axons in the peripheral and central nervous systems; it is more diffusely and persistently expressed in gray matter and on unmyelinated axons. Immunoelectron microscopy demonstrated that Caspr is localized to the septate-like junctions that form between axons and the paranodal loops of myelinating cells. Caspr is poorly extracted by nonionic detergents, suggesting that it is associated with the axon cytoskeleton at these junctions. These results indicate that contactin and Caspr function independently during myelination and that their expression is regulated by glial ensheathment. They strongly implicate Caspr as a major transmembrane component of the paranodal junctions, whose molecular composition has previously been unknown, and suggest its role in the reciprocal signaling between axons and glia.
Skip Nav Destination
Article navigation
15 December 1997
Article|
December 15 1997
The Axonal Membrane Protein Caspr, a Homologue of Neurexin IV, Is a Component of the Septate-like Paranodal Junctions That Assemble during Myelination
Steven Einheber,
Steven Einheber
*Department of Cell Biology, ‡Department of Neurology, §The Kaplan Cancer Center, New York University Medical School, New York 10016; ‖Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104; ¶Department of Neurology and Neuroscience, Division of Neurobiology, Cornell University Medical College, New York 10021; and **Sugen, Inc., Redwood City, California 94063
Search for other works by this author on:
George Zanazzi,
George Zanazzi
*Department of Cell Biology, ‡Department of Neurology, §The Kaplan Cancer Center, New York University Medical School, New York 10016; ‖Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104; ¶Department of Neurology and Neuroscience, Division of Neurobiology, Cornell University Medical College, New York 10021; and **Sugen, Inc., Redwood City, California 94063
Search for other works by this author on:
William Ching,
William Ching
*Department of Cell Biology, ‡Department of Neurology, §The Kaplan Cancer Center, New York University Medical School, New York 10016; ‖Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104; ¶Department of Neurology and Neuroscience, Division of Neurobiology, Cornell University Medical College, New York 10021; and **Sugen, Inc., Redwood City, California 94063
Search for other works by this author on:
Steven Scherer,
Steven Scherer
*Department of Cell Biology, ‡Department of Neurology, §The Kaplan Cancer Center, New York University Medical School, New York 10016; ‖Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104; ¶Department of Neurology and Neuroscience, Division of Neurobiology, Cornell University Medical College, New York 10021; and **Sugen, Inc., Redwood City, California 94063
Search for other works by this author on:
Teresa A. Milner,
Teresa A. Milner
*Department of Cell Biology, ‡Department of Neurology, §The Kaplan Cancer Center, New York University Medical School, New York 10016; ‖Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104; ¶Department of Neurology and Neuroscience, Division of Neurobiology, Cornell University Medical College, New York 10021; and **Sugen, Inc., Redwood City, California 94063
Search for other works by this author on:
Elior Peles,
Elior Peles
*Department of Cell Biology, ‡Department of Neurology, §The Kaplan Cancer Center, New York University Medical School, New York 10016; ‖Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104; ¶Department of Neurology and Neuroscience, Division of Neurobiology, Cornell University Medical College, New York 10021; and **Sugen, Inc., Redwood City, California 94063
Search for other works by this author on:
James L. Salzer
James L. Salzer
*Department of Cell Biology, ‡Department of Neurology, §The Kaplan Cancer Center, New York University Medical School, New York 10016; ‖Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104; ¶Department of Neurology and Neuroscience, Division of Neurobiology, Cornell University Medical College, New York 10021; and **Sugen, Inc., Redwood City, California 94063
Search for other works by this author on:
Steven Einheber
*Department of Cell Biology, ‡Department of Neurology, §The Kaplan Cancer Center, New York University Medical School, New York 10016; ‖Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104; ¶Department of Neurology and Neuroscience, Division of Neurobiology, Cornell University Medical College, New York 10021; and **Sugen, Inc., Redwood City, California 94063
George Zanazzi
*Department of Cell Biology, ‡Department of Neurology, §The Kaplan Cancer Center, New York University Medical School, New York 10016; ‖Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104; ¶Department of Neurology and Neuroscience, Division of Neurobiology, Cornell University Medical College, New York 10021; and **Sugen, Inc., Redwood City, California 94063
William Ching
*Department of Cell Biology, ‡Department of Neurology, §The Kaplan Cancer Center, New York University Medical School, New York 10016; ‖Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104; ¶Department of Neurology and Neuroscience, Division of Neurobiology, Cornell University Medical College, New York 10021; and **Sugen, Inc., Redwood City, California 94063
Steven Scherer
*Department of Cell Biology, ‡Department of Neurology, §The Kaplan Cancer Center, New York University Medical School, New York 10016; ‖Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104; ¶Department of Neurology and Neuroscience, Division of Neurobiology, Cornell University Medical College, New York 10021; and **Sugen, Inc., Redwood City, California 94063
Teresa A. Milner
*Department of Cell Biology, ‡Department of Neurology, §The Kaplan Cancer Center, New York University Medical School, New York 10016; ‖Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104; ¶Department of Neurology and Neuroscience, Division of Neurobiology, Cornell University Medical College, New York 10021; and **Sugen, Inc., Redwood City, California 94063
Elior Peles
*Department of Cell Biology, ‡Department of Neurology, §The Kaplan Cancer Center, New York University Medical School, New York 10016; ‖Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104; ¶Department of Neurology and Neuroscience, Division of Neurobiology, Cornell University Medical College, New York 10021; and **Sugen, Inc., Redwood City, California 94063
James L. Salzer
*Department of Cell Biology, ‡Department of Neurology, §The Kaplan Cancer Center, New York University Medical School, New York 10016; ‖Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104; ¶Department of Neurology and Neuroscience, Division of Neurobiology, Cornell University Medical College, New York 10021; and **Sugen, Inc., Redwood City, California 94063
Address all correspondence to Dr. James L. Salzer, Department of Cell Biology, New York University Medical School, 550 First Avenue, New York, NY 10016. Tel.: (212) 263-5358. Fax: (212) 263-8139.
Elior Peles' current address is Department of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot, Israel.
Received:
August 21 1997
Revision Received:
September 30 1997
Online ISSN: 1540-8140
Print ISSN: 0021-9525
1997
J Cell Biol (1997) 139 (6): 1495–1506.
Article history
Received:
August 21 1997
Revision Received:
September 30 1997
Citation
Steven Einheber, George Zanazzi, William Ching, Steven Scherer, Teresa A. Milner, Elior Peles, James L. Salzer; The Axonal Membrane Protein Caspr, a Homologue of Neurexin IV, Is a Component of the Septate-like Paranodal Junctions That Assemble during Myelination . J Cell Biol 15 December 1997; 139 (6): 1495–1506. doi: https://doi.org/10.1083/jcb.139.6.1495
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement
Advertisement